Detalhe da pesquisa
1.
Olaparib maintenance therapy for platinum-sensitive relapsed ovarian cancer at a single institution: A retrospective study.
J Obstet Gynaecol Res
; 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38742699
2.
Platinum rechallenge treatment using gemcitabine plus carboplatin with or without bevacizumab for platinum-resistant ovarian cancer.
Int J Clin Oncol
; 27(4): 790-801, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34985551
3.
MicroRNA-135a-3p as a promising biomarker and nucleic acid therapeutic agent for ovarian cancer.
Cancer Sci
; 108(5): 886-896, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28231414
4.
Cytoreduction of diaphragmatic metastasis from ovarian cancer with involvement of the liver using a ventral liver mobilization technique.
Gynecol Oncol
; 140(3): 577-9, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26801940
5.
Association of Chemotherapy Response Score with Multidrug Resistance 1 and CA125 ELIMination Rate Constant K in Patients with Advanced Ovarian Cancer Treated with Neoadjuvant Chemotherapy.
Kurume Med J
; 2024 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38556270
6.
N-Myc Downstream Regulated Gene-1 May Play an Important Role in the Prognosis of Ovarian Cancer, in Its Association with Beta-Catenin.
Kurume Med J
; 69(1.2): 39-46, 2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37793886
7.
Association of Serum HB-EGF Value and Response to Chemotherapy in Patients with Recurrent Ovarian Cancer.
Anticancer Res
; 38(7): 4347-4351, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29970572
8.
Comparison of secondary cytoreductive surgery plus chemotherapy with chemotherapy alone for recurrent epithelial ovarian, tubal, or peritoneal carcinoma: A propensity score-matched analysis of 112 consecutive patients.
Medicine (Baltimore)
; 96(37): e8006, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28906381
9.
HB-EGF Is a Promising Therapeutic Target for Lung Cancer with Secondary Mutation of EGFRT790M.
Anticancer Res
; 37(7): 3825-3831, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28668882
10.
Serum Heparin-binding Epidermal Growth Factor-like Growth Factor (HB-EGF) as a Biomarker for Primary Ovarian Cancer.
Anticancer Res
; 37(7): 3955-3960, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28668900
11.
Clinical Efficacy of Aprepitant in Patients with Gynecological Cancer after Chemotherapy Using Paclitaxel and Carboplatin.
Anticancer Res
; 35(8): 4527-34, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26168497
12.
The Safety of Pegylated Liposomal Doxorubicin Plus Irinotecan in Recurrent Ovarian Cancer Patients: A Phase I Trial.
Anticancer Res
; 35(8): 4521-5, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26168496